Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 216, pseudogene (RN7SL216P)

Target
RN7SL216P
Molecular classification
Other (Pseudogene)
01

Overview

RNA, 7SL, cytoplasmic 216, pseudogene (RN7SL216P) is a non-coding RNA sequence found on human chromosome 3[2]. It is part of a large family of pseudogenes derived from the functional signal recognition particle RNA gene (7SL RNA), which is important in protein targeting within cells[1][3]. Most 7SL RNA pseudogenes in human DNA, including RN7SL216P, are thought to result from the reverse transcription and integration of RNA sequences back into the genome[7]. These pseudogenes are typically truncated, lack expression, and do not produce functional RNA or protein products, making them non-functional in biological processes[2][5][7]. No alternative names, disease roles, drug interactions, or biomarker uses have been described for RN7SL216P. Key points: - RN7SL216P is classified strictly as a pseudogene, not a functional receptor, protein, or drug target[2][5][7]. - No known aliases, functions, disease links, or drug interactions. - Entry is likely inappropriate as a therapeutic target due to pseudogene status; this is a common issue when pseudogenes are confused with functional molecule targets.

02

Mechanism of action

None—no drugs target this pseudogene.

03

Biological functions

None specific to RN7SL216P; as a pseudogene, it likely has no major biological function.Some pseudogenes can act as regulatory RNAs in gene expression or as microRNA sponges, but there is no evidence RN7SL216P does so.
04

Disease associations

None reported for RN7SL216P specifically.Other pseudogenes have roles in cancer and disease by interfering with gene regulation, but no data for this particular gene.
05

Safety considerations

None known—this pseudogene is not a functional therapeutic target.

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 216, pseudogene (RN7SL216P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 216, pseudogene (RN7SL216P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call